Fibromyalgia: Why It Hurts Everywhere — and What Works

What Is Fibromyalgia?

Fibromyalgia (FM) is a chronic widespread pain syndrome characterized by diffuse musculoskeletal pain, fatigue, sleep disturbances, cognitive dysfunction, and a series of other somatic symptoms. It is the second most common rheumatologic condition, second only to osteoarthritis.

Unlike conditions such as arthritis or disc herniation, fibromyalgia shows no detectable structural or inflammatory lesions in peripheral tissues. The disease results from a dysfunction in central pain processing — the brain and spinal cord amplify pain signals, turning normal stimuli into painful experiences.

Fibromyalgia is classified as a central sensitization syndrome, alongside other conditions such as irritable bowel syndrome, chronic tension-type headache, and chronic fatigue syndrome. Recognizing it as a real neurological condition, and not "psychological" or "imaginary", is fundamental for proper treatment.

Epidemiology

Fibromyalgia affects 2-4% of the general population and is more prevalent in women. However, recent studies with updated diagnostic criteria suggest that the gender difference may be smaller than previously thought — many men with fibromyalgia are not diagnosed.

Risk factors include female sex, family history of fibromyalgia (strong genetic component), physical or emotional trauma, chronic inflammatory diseases (RA, lupus — secondary fibromyalgia), mood disorders (depression, anxiety), and severe infections. Fibromyalgia frequently coexists with other chronic painful conditions.

Pathophysiology

Fibromyalgia is a disorder of central pain processing. The central nervous system of patients with FM presents an "amplification" of sensory signals, such that stimuli that normally would not be painful are perceived as pain (allodynia) and mildly painful stimuli are perceived as very painful (hyperalgesia).

Neurobiological Mechanisms

Central sensitization: neurons in the dorsal horn of the spinal cord and thalamus are hyperexcitable, amplifying all sensory signals. Functional magnetic resonance imaging studies show that patients with FM activate brain regions of pain with pressure stimuli 50% lower than healthy controls.

Dysfunction of descending inhibitory pathways: normally, the brain sends signals that "filter" and reduce pain perception. In FM, this filtering system is impaired. Neurotransmitters such as serotonin and norepinephrine, which mediate this inhibition, are at reduced levels in the cerebrospinal fluid of patients with FM.

Neurotransmitter alterations: 3-fold increase in substance P (excitatory pain neurotransmitter) in cerebrospinal fluid, decrease in serotonin and norepinephrine, and alterations in glutamate levels in pain processing brain areas (insula).

The Role of Sleep

Disturbances in slow-wave sleep (stage N3) are a consistent finding in FM. Deep sleep is when muscle restoration and modulation of pain systems occur. Experimental studies have demonstrated that selective deprivation of slow-wave sleep in healthy volunteers reproduces fibromyalgia symptoms (diffuse pain, fatigue, cognitive difficulty).

Alpha-wave intrusion into delta sleep (the "alpha-delta" pattern) is a classic polysomnographic finding in FM. This pattern indicates that the brain "wakes up" repeatedly during deep sleep, preventing adequate restoration.

Symptoms

Fibromyalgia is a multi-symptom syndrome. Beyond widespread pain, patients frequently present a constellation of symptoms reflecting generalized dysfunction of central sensory processing.

Diagnosis

Fibromyalgia diagnosis is clinical — no laboratory or imaging test confirms the disease. Diagnostic criteria have evolved over time: the 18 tender points of 1990 were replaced by more comprehensive criteria in 2010/2016.

Laboratory tests are requested not to confirm FM, but to exclude other conditions that mimic its symptoms, such as hypothyroidism, rheumatoid arthritis, lupus, vitamin D deficiency, and polymyalgia rheumatica.

Hypothyroidism

Hypothyroidism is one of the most important mimics of fibromyalgia and should be excluded in all patients with suspected FM. Shared symptoms are many: diffuse muscle pain, fatigue, sleep disturbances, cognitive difficulty ("fibro fog"), weight gain, and depression. The key clinical difference is that hypothyroidism presents with cold intolerance, dry skin, hair loss, constipation, and slow reflexes — findings absent in FM.

Measuring TSH and free T4 is mandatory in the initial workup of any patient with suspected fibromyalgia. Note that fibromyalgia and hypothyroidism can coexist: well-controlled hypothyroidism that does not resolve all musculoskeletal symptoms may have associated fibromyalgia.

Polymyalgia Rheumatica

Polymyalgia rheumatica (PMR) occurs in patients over 50 and causes pain and stiffness in the shoulder (shoulders and neck) and pelvic (hips and thighs) girdles. Proximal pain distribution, intense morning stiffness, and markedly elevated ESR and CRP distinguish PMR from fibromyalgia — in FM, laboratory tests are normal.

A therapeutic trial with low-dose corticosteroid is highly suggestive: PMR responds dramatically and rapidly (within 24-48 hours) to prednisone 15-20 mg/day, whereas fibromyalgia does not respond to corticosteroids. PMR can be associated with giant cell arteritis (temporal arteritis), which can cause blindness and requires urgent treatment.

Diffuse Myofascial Pain vs. Fibromyalgia

Myofascial pain syndrome (MPS) and FM share musculoskeletal pain but differ in mechanism and distribution. MPS features specific, localized myofascial trigger points (taut bands in the muscle with characteristic referred pain) without the generalized central sensitization of FM. MPS may be regional (one muscle group) or more diffuse.

FM involves generalized pain throughout the body along with sleep disturbances, fatigue, and cognitive dysfunction not seen in pure MPS. The two conditions can coexist, and acupuncture is highly effective in treating myofascial trigger points, making it a valuable therapeutic option in both.

Treatments

Fibromyalgia treatment is multidisciplinary, combining non-pharmacological and pharmacological approaches. No single medication resolves all symptoms. Aerobic exercise is the intervention with the highest level of evidence.

Non-Pharmacological Treatment

Aerobic exercise is the best-evidenced treatment for FM. Programs of 30-40 minutes, 2-3 times per week, of moderate intensity (walking, swimming, cycling) reduce pain, fatigue, and depression. The mechanism involves activation of descending inhibitory pathways and release of endorphins.

Cognitive-behavioral therapy (CBT) is highly effective for fibromyalgia. It helps patients modify catastrophic thoughts about pain, develop coping strategies, and improve self-efficacy. The combination of exercise with CBT shows the best long-term results.

Sleep hygiene is essential: regular schedules, dark and cool environment, avoiding screens before bed, limiting caffeine and alcohol. Since sleep disturbance is central in FM, improvements in this area impact all other symptoms.

Pharmacotherapy

Duloxetine is a serotonin and norepinephrine reuptake inhibitor (SNRI) approved for FM. By increasing these neurotransmitters in the descending inhibitory pain pathways, it partially restores the brain's ability to modulate painful signals. Initial dose of 30 mg/day, titrated to 60 mg after 1 week.

Pregabalin acts by binding to the alpha-2-delta subunit of voltage-dependent calcium channels, reducing the release of excitatory neurotransmitters (glutamate, substance P) in the dorsal horn of the spinal cord. Dose of 75-225 mg twice daily. Improves pain, sleep, and anxiety, but may cause dizziness and weight gain.

Amitriptyline in low doses (10-50 mg at night) is one of the oldest and most effective treatments for FM. It improves sleep quality, reduces pain, and is inexpensive. Side effects include dry mouth, constipation, and drowsiness, which can be advantageous or limiting.

Acupuncture as Treatment

Acupuncture is one of the most studied complementary therapies for fibromyalgia. A Cochrane review described moderate effects of acupuncture, especially electroacupuncture, on pain and stiffness compared with placebo, with limited evidence quality and heterogeneity between studies. Response varies: some patients improve markedly, others partially, and a fraction does not respond.

In FM, acupuncture's mechanisms of action are particularly relevant: activation of descending inhibitory pathways (deficient in FM), release of endorphins and enkephalins, modulation of serotonin and norepinephrine levels in the central nervous system, and reduction of substance P levels in cerebrospinal fluid.

Functional neuroimaging studies demonstrate that acupuncture modulates activity in brain regions involved in pain processing in FM, including the insula, anterior cingulate cortex, and somatosensory cortex — the same regions that show hyperactivity in the disease.

Prognosis

Fibromyalgia is a chronic condition — there is no definitive cure. However, with adequate multidisciplinary treatment, many patients achieve adequate symptom control and functional improvement. Response magnitude varies: some achieve marked improvement, others partial improvement, and a fraction has limited response. Improvement, when it occurs, happens gradually over months.

Myths and Facts

When to Seek Medical Help